Breaking news
Drugmaker AstraZeneca is now injecting people with its new antibody treatment for Covid-19 in a bid to see if it will protect people and also help the already sick. The company, which is also manufacturing a vaccine hopeful made by Oxford University scientists, hope the treatment will be a coronavirus breakthrough. Called monoclonal antibody therapy, … Read more
Pharmaceutical giant AstraZeneca has dismissed claims its experimental Covid-19 vaccine could be fast-tracked in the US amid reports Donald Trump wants to get it approved before the presidential election this autumn. White House insiders claim the US President is considering speeding up regulatory approval for the jab, originally developed by Oxford University scientists. Getting a … Read more
Astrazeneca signs deals to sell coronavirus vaccine to Argentina and Mexico By Matt Oliver For The Daily Mail Published: 21:50 BST, 13 August 2020 | Updated: 21:50 BST, 13 August 2020 Astrazeneca is forging ahead with its potential coronavirus vaccine after signing fresh supply deals in Latin America. Argentina and Mexico are the latest countries … Read more
AstraZeneca and Johnson & Johnson promised to offer their coronavirus vaccines to the US at cost during testimony before a Congressional committee on Tuesday. UK-based Astrazeneca also said that it would ramp up production of its prospective vaccine – created with Oxford University – to ensure that 300 million doses are available to the US … Read more
Drug duo Astrazeneca and Synairgen shares soar as they declare major breakthroughs in battle to develop Covid vaccine and treatment By Matt Oliver For The Daily Mail Published: 21:50 BST, 20 July 2020 | Updated: 22:15 BST, 20 July 2020 Pioneering British drugs companies declared major breakthroughs in the battle against coronavirus yesterday – sending … Read more
British pharmaceutical giant AstraZeneca has struck a deal to supply Europe with a coronavirus vaccine. The Cambridge-based firm has agreed to dish out up to 400million doses of its unproven jab in Germany, France, Italy and the Netherlands. Its AZD1222 vaccine, developed by Oxford University, is currently being trialled on more than 10,000 people and results are expected … Read more
AstraZeneca approaches US rival Gilead Sciences to discuss merger By Daily Mail City & Finance Reporter Published: 21:52 BST, 7 June 2020 | Updated: 21:52 BST, 7 June 2020 In what would be the largest healthcare deal on record, AstraZeneca has approached its US rival Gilead Sciences to discuss a merger. AstraZeneca, which is listed … Read more
A British pharmaceutical giant is already manufacturing its unproven coronavirus vaccine as it hopes to dish out hundreds of millions of doses by September. AstraZeneca has started to mass-produce its AZD1222 jab, being developed by Oxford University, at factories in India, Oxford, Switzerland and Norway. The Cambridge-based firm expects to have made and distributed hundreds of millions … Read more
British people will be able to access a coronavirus vaccine from September, the chief executive of drug maker AstraZeneca has said, despite concerns it will not be ready. Pascal Soriot told The Andrew Marr Show on Sunday that British people will get first access to the vaccine from autumn. The pharmaceutical firm, which is working … Read more
Pharmaceutical giant AstraZeneca has capacity to make ONE BILLION doses of Oxford University’s experimental COVID-19 vaccine amid hopes it could be ready for September UK has reportedly ordered 100million doses for a population of 66million people The vaccine is still in trials but could eradicate COVID-19 if it proves effective Experts sceptical about a short … Read more